Table 1.
Patient Demographics for the Validation and Evaluation Cohorts
| Patient Demographics | Validation Cohort n=200 | Evaluation Cohort n=285 | ||
|---|---|---|---|---|
| Number (%) | Mean (standard deviation) | Number (%) | Mean (standard deviation) | |
| % Male | 97(49) | 139 (49) | ||
| Age at diagnosis, years | 48.6 (15.6) | 55.1 (13.2) | ||
| Duration of diabetes, years | 16.3 (11.9) | 6.7 (7.4) | ||
| BMI kg/m2 | 33.2 (7.1) | 33.1 (6.2) | ||
| Systolic BP mmHg | 125 (15) | 131 (16) | ||
| Diastolic BP mm Hg | 69 (10) | 72.6 (10.5) | ||
| HbA1c % | 7.3 (1.1) | 7.6 (1.6) | ||
| LDL Cholesterol mmol/l | 2.2 (0.7) | 2.7 (0.9) | ||
| UKPDS 10-year risk of CHD | 25 (11) | 21 (15) | ||
| Performance Metrics | Number (%) | Number (%) | ||
| % HbA1c<7 % | 86 (43) | 115 (40) | ||
| % BP<130/80 mmHg | 113 (57) | 115 (40) | ||
| %LDL< 2.6 mmol/l | 157 (79) | 127 (45) | ||